Risk factors related to the SARS‐CoV‐2 vaccine additional doses hesitancy among pregnant and non‐pregnant people of reproductive age and partners: A Brazilian cross‐sectional study
- 26 March 2024
- journal article
- research article
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 166 (3) , 1144-1160
Abstract
Objective: The aim of this study was to assess the predictors of acceptance and hesitancy of additional doses of any SARS‐CoV‐2 (COVID‐19) vaccine among pregnant or recently pregnant and non‐pregnant people of reproductive age and partners in Brazil.Methods: We conducted an online cross‐sectional study from June 2022 to April 2023 and invited women and partners between 18 and 49 years old to participate. We employed a snowball strategy to reach all potential eligible participants. Our primary outcome was the acceptance rate of the COVID‐19 booster vaccine. We estimated the frequency and percentage for the three groups and compared categorical variables using the Chi‐square test. Moreover, bivariate, backward stepwise regression, and subgroup analyses were performed to evaluate risk factors and predictors of COVID‐19 vaccine booster hesitancy. We reported the effect size as OR with a 95% CI.Results: We included 1487 participants, and among them, 334 (22.5%) were pregnant or recently pregnant people, 905 (60.8%) were non‐pregnant people, and 247 (16.6%) were male partners. Pregnant and recently pregnant people showed greater hesitancy for the COVID‐19 vaccine booster than non‐pregnant people (28% vs 15%, P < 0.001) and male partners (28% vs 16%, P < 0.001). Non‐pregnant women accepted the COVID‐19 vaccine more often than pregnant or recently pregnant people (OR 1.75; 95% CI: 1.13–2.70). The associated factors to the reduced COVID‐19 vaccine booster acceptance were family income between US$ 566–945.00 (54%), evangelic religion (65%), concern about vaccine safety (80%) and perceived common vaccine importance (93%).Conclusion: Pregnant people were more hesitant than non‐pregnant people to accept the COVID‐19 booster vaccine. Family income, religious beliefs, vaccine safety concerns, and perceived common vaccine importance were significant barriers to accepting COVID‐19 booster vaccines. The impact of these factors was more evident among pregnant or recently pregnant people, emphasizing the harmful effect of misinformation among this vulnerable population.Keywords
Funding Information
- World Health Organization
This publication has 41 references indexed in Scilit:
- One Vax Two Lives: a social media campaign and research program to address COVID-19 vaccine hesitancy in pregnancyAmerican Journal of Obstetrics and Gynecology, 2022
- Involvement of political and socio-economic factors in the spatial and temporal dynamics of COVID-19 outcomes in Brazil: A population-based studyThe Lancet Regional Health - Americas, 2022
- Protective Behaviors Associated With Gender During the 2018-2020 Ebola Outbreak in Eastern Democratic Republic of the CongoJAMA Network Open, 2022
- Spatial clusters, social determinants of health and risk of maternal mortality by COVID-19 in Brazil: a national population-based ecological studyThe Lancet Regional Health - Americas, 2021
- COVID-19 vaccine acceptance among pregnant, breastfeeding, and nonpregnant reproductive-aged womenAmerican Journal of Obstetrics & Gynecology MFM, 2021
- Pregnant People’s Paradox—Excluded From Vaccine Trials Despite Having a Higher Risk of COVID-19 ComplicationsJAMA, 2021
- COVID-19 vaccine acceptance among pregnant women and mothers of young children: results of a survey in 16 countriesEuropean Journal of Epidemiology, 2021
- Nudging Immunity: The Case for Vaccinating Children in School and Day Care by DefaultHEC Forum, 2019
- WHO’s Top Health Threats for 2019JAMA, 2019
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2009